NCT00559052 - An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Exocrine Pancreatic Insufficiency

Interventions

DRUG

VIOKASE 16

The VIOKASE 16 is to be taken as 3 tablets with the perfusion procedure.

Trial Locations (2)

Shands Hospital, University of Florida, Gainesville

Santhi Swaroop Vege, M.D., Mayo Clinic- Rochester